Anti-phospholipid antibodies in the setting of thromboembolic events associated with severe COVID-19 pneumonia

BACKGROUND: Thrombotic consequences have been reported in COVID-19-infected patients, especially those who are critically ill. Multiple studies have tested antiphospholipid antibodies (aPLs) among COVID-19 patients, but to date, the actual frequency of aPLs is still uncharted. In this cohort study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Badr, Omaima Ibrahim, Elrefaey, Wael Aly, Abu-Zaid, Mohammed Hassan, Elmedany, Samah Hamdy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763422/
http://dx.doi.org/10.1186/s43166-021-00105-x

Ejemplares similares

Ejemplares similares